Shanjia Ke

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages

Jingjing Huang, Huayang Pan, Jing Sun et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 65 citations · Full text

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis

Shounan Lu, Shanjia Ke, Chaoqun Wang et al. · Oncogenesis · 2022 · 34 citations · Full text

Egfr-stat3 Axis, Nnmt Expression, Pathology +18

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway

Zhigang Feng, Shanjia Ke, Chaoqun Wang et al. · Oncogene · 2023 · 32 citations

Srsf1-erk Pathway, Liver Cancer, Medicine +4

HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway

Yanan Xu, Shanjia Ke, Shounan Lu et al. · Oncogenesis · 2023 · 31 citations · Full text

LncRNA Hnf4αos exacerbates liver ischemia/reperfusion injury in mice via Hnf4αos/Hnf4α duplex-mediated PGC1α suppression

Chaoqun Wang, Hongjun Yu, Shounan Lu et al. · Redox Biology · 2022 · 20 citations · Full text

Opposite Strand, Immunology, Novel Lncrna +22